Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bicyclic androgen receptor antagonists pursued at BMS

Sep. 8, 2003

Japanese group identifies new antiangiogenic/antimetastatic MMP inhibitor

Sep. 8, 2003

Micromet to develop CAT's EpCAM-targeting antibody

Sep. 8, 2003

Two new phase I trials investigate Xcytrin plus Taxotere for advanced cancers

Sep. 8, 2003

Kylix describes new Tie-2/KDR inhibitors and their use

Sep. 5, 2003

Avidex and Dow to develop biotargeted radiopharmaceuticals for cancer

Sep. 5, 2003

Satraplatin phase III trial cleared to begin

Sep. 4, 2003

TLK-286 awarded fast track status for advanced ovarian cancer

Sep. 4, 2003

Cathepsin B as a therapeutic target in cancer and arthritis

Sep. 4, 2003

Novel CDK inhibitors described in recent Warner-Lambert patent

Sep. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...